A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
about
Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Psi-RNA.New pandemics: HIV and AIDS, HCV and chronic hepatitis, influenza virus and fluEquine infectious anemia virus Gag p9 function in early steps of virus infection and provirus productionIdentification of HIV-1 inhibitors targeting the nucleocapsid protein.Phages and HIV-1: from display to interplay.Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase.Initial therapy for human immunodeficiency virus: broadening the options.HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation.Nucleocapsid protein function in early infection processes.The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function.Nucleic acid binding properties of the simian immunodeficiency virus nucleocapsid protein NCp8.Structure of the zinc finger domain encompassing residues 13-51 of the nucleocapsid protein from simian immunodeficiency virus.Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era.Nucleocapsid Annealing-Mediated Electrophoresis (NAME) assay allows the rapid identification of HIV-1 nucleocapsid inhibitors.Design, synthesis and biological evaluation of TAR and cTAR binders as HIV-1 nucleocapsid inhibitors
P2860
Q25255792-B7F549FC-2F6A-418B-B0AE-F96909635580Q27478093-CA598445-9DB6-43A8-BD22-D43531B9A292Q33883977-1455952B-C57D-4B9D-BC7F-7C20FAD991B2Q34269543-A5CD5B90-CB26-44DE-ABA0-EDB87A6C5577Q34273397-7E16105F-BAD4-481B-81C8-89B128504DCAQ34616490-2A47BA37-A331-4424-96B8-8E32B45925EBQ35705540-843FA85F-E870-4A1D-BD6E-38CAE9E290FFQ35759609-0C2E1D3A-6F08-4686-8FFC-7C9A5B36A48EQ35761626-B76F62BC-70BA-429C-9AA7-E112F355AFAFQ35893976-B76F39E4-CA4B-4A14-820C-B03381229178Q37086413-42EDC906-83C9-40A5-B312-71D074B458DEQ37419637-E5003B36-2F03-4F0D-94A6-65453AFDCCD0Q38313814-232CDF9B-45F9-4786-B138-6BAF394FE2B2Q38319853-F9B37247-5D72-4D27-97D7-8330529143A1Q38524164-650D2A5F-4B8A-4AE9-A77E-3984C487BE8AQ39402465-B57FC570-3EDB-4FDF-B005-EF3DAA027AFCQ41928050-A328AEE8-27DF-4C31-B13C-5E761C2D93B7Q42105637-EF98E773-7E16-4BAB-B465-F0D2921F49BBQ57588992-7CC71BF5-7970-4BD0-858E-705FBFBC0907
P2860
A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
A mimic of HIV-1 nucleocapsid ...... d displays antiviral activity.
@ast
A mimic of HIV-1 nucleocapsid ...... d displays antiviral activity.
@en
type
label
A mimic of HIV-1 nucleocapsid ...... d displays antiviral activity.
@ast
A mimic of HIV-1 nucleocapsid ...... d displays antiviral activity.
@en
prefLabel
A mimic of HIV-1 nucleocapsid ...... d displays antiviral activity.
@ast
A mimic of HIV-1 nucleocapsid ...... d displays antiviral activity.
@en
P2093
P2860
P356
P1476
A mimic of HIV-1 nucleocapsid ...... d displays antiviral activity.
@en
P2093
Bousseau A
Druillennec S
Fournié-Zaluski MC
P2860
P304
P356
10.1073/PNAS.96.9.4886
P407
P577
1999-04-01T00:00:00Z